Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
The tumour microenvironment is an important aspect of cancer science that contributes to tumour initiation, tumour progression and responses to therapy. Cells and molecules of the immune system are fundamental components of the tumour microenvironment.
The composition and characteristics of the tumour microenvironment vary widely and are important in determining the anti-tumour immune response. For example, certain cells of the immune system, including natural killer cells, dendritic cells (DCs) and effector T cells, are capable of driving potent anti-tumour responses. However, tumour cells often induce an immunosuppressive microenvironment, which favours the development of immunosuppressive populations of immune cells, such as myeloid-derived suppressor cells and regulatory T cells. Understanding the complexity of immunomodulation by tumours is important for the development of immunotherapy. Various strategies are being developed to enhance anti-tumour immune responses, including DC-based vaccines and antagonists of inhibitory signalling pathways to overcome 'immune checkpoints'.
Tumour microenvironment include important sessions like:
Signaling pathways in stroma and cancers
Cancer stem cells
Cancer and the immune system
Animal models of cancer
Therapeutical implications: from bench to bedside
Tumour microenvironment
OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 350 leading-edge peer reviewed Open Access journals and has organised over 300 scientific conferences all over the world. OMICS Publishing Group journals have over 3.5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing. OMICS Group International Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations. Now focusing on Diagnostic Imaging conference to provide a better platform for the Researchers, Doctors to share their views & knowledge.
The Global Cancer Conference & Medicare Summit, hosted by the OMICS Group. It was held during September 15-17, 2014 at Hyderabad, India. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from scientists, researchers and leaders from cancer related industries, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS Group.
Conferences
EMBO EMBL Symposium Tumour Microenvironment and Signalling
Venue: EMBL
Location: Heidelberg, Germany
BEGINS: May 07, 2014Ends May 10, 2014
11th International Congress on Targeted Therapies in Cancer
Venue: Renaissance Washington, DC Downtown Hotel
Location: Washington, Washington, United States
BEGINS: Aug 16, 2013 07:00 AMEnds Aug 17, 2013 03:30 PM
Keystone Symposia Cancer Immunology and Immunotherapy
Venue: Fairmont Hotel Vancouver
Location: Vancouver, British Columbia, Canada
BEGINS: Jan 27, 2013Ends Feb 01, 2013
40th Congress of the International Society of Oncology and Biomarkers (ISOBM)
Venue: Ramada Jerusalem Hotel
Location: Jerusalem, 91033, Israel
BEGINS: Oct 14, 2012Ends Oct 17, 2012
The 1st Annual Meeting of the Middle-Eastern Association for Cancer Reseach
Venue: Tanta University Convention Center
Location: Tanta, Gharbia, Egypt
BEGINS: Dec 27, 2011Ends Dec 29, 2011
Immunochemotherapy Correcting Immune Escape in Cancer
Venue: Philadelphia
Location: Philadelphia, United States
BEGINS: Mar 10, 2011Ends Mar 11, 2011
Ninth International Congress on Targeted Therapies in Cancer
Venue: TBA
Location: Washington, Washington DC, United States
BEGINS: Aug 20, 2010Ends Aug 22, 2010
Cancer Immunotherapy Immunomonitoring
Venue: Kiev
Location: Kiev, Ukraine
BEGINS: May 18, 2009Ends May 21, 2009
2nd Annual Immunodiagnostics Immunomonitoring Conference
Venue: Washington, DC
Location: Washington, DC, United States
BEGINS: Dec 06, 2007Ends Dec 07, 2007
Companies
Bavarian Nordic, Mountain View, CA
Juvaris, Pleasanton, CA
PaxVax, San Diego, CA
MSD, Ireland
Genocea Bioscience, Cambridge, MA
This page will be updated regularly.
This page was last updated on April 20, 2024